A Case Control Study of Resveratrol Effects in Coronary Artery Disease Patients With Metabolic Syndrome

NCT02137421 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Metabolic Syndrome
Coronary Artery Disease

Interventions

DIETARY_SUPPLEMENT: Resveratrol (3, 4´, 5 trihydroxystilbene)

Sponsor

Tehran University of Medical Sciences